{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:03:29Z","timestamp":1780959809612,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Open Foundation of Key Laboratory of Blood Safety Research of Zhejiang Province","award":["2022KF003"],"award-info":[{"award-number":["2022KF003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16062-7","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:04:45Z","timestamp":1777071885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IL-8 and sCD40L predict platelet refractoriness and survival of pediatric patients with solid tumors receiving chemotherapy"],"prefix":"10.1186","volume":"26","author":[{"given":"Chao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"issue":"6","key":"16062_CR1","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3324\/haematol.2021.279512","volume":"107","author":"DJ Kuter","year":"2022","unstructured":"Kuter DJ. Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies. Haematologica. 2022;107(6):1243\u201363.","journal-title":"Haematologica"},{"issue":"3","key":"16062_CR2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2141.2008.07189.x","volume":"142","author":"E Hod","year":"2008","unstructured":"Hod E, Schwartz J. Platelet transfusion refractoriness. Br J Haematol. 2008;142(3):348\u201360.","journal-title":"Br J Haematol"},{"issue":"7","key":"16062_CR3","first-page":"1484","volume":"69","author":"C Zhou","year":"2023","unstructured":"Zhou C, Xu J, Ma J, Yin M, Cai S, Chen X. Responsiveness to Platelet Transfusions in Pediatric Patients with Thrombocytopenia: Incidence, Clinical Variables. Clin Lab. 2023;69(7):1484\u201392.","journal-title":"Clin Lab"},{"key":"16062_CR4","first-page":"5589768","volume":"2021","author":"S Arabi","year":"2021","unstructured":"Arabi S, Almahayni AO, Alomair AA, Masuadi EM, Damlaj M, Al-Dorzi HM, Prevalence. Risk Factors, and Outcomes of Platelet Transfusion Refractoriness in Critically Ill Patients: A Retrospective Cohort Study. Crit Care Res Pract. 2021;2021:5589768.","journal-title":"Crit Care Res Pract"},{"key":"16062_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.leukres.2017.08.015","volume":"61","author":"T Comont","year":"2017","unstructured":"Comont T, Tavitian S, Bardiaux L, Fort M, Debiol B, Morere D, et al. Platelet transfusion refractoriness in patients with acute myeloid leukemia treated by intensive chemotherapy. Leuk Res. 2017;61:62\u20137.","journal-title":"Leuk Res"},{"issue":"3","key":"16062_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/bjh.13597","volume":"171","author":"SJ Stanworth","year":"2015","unstructured":"Stanworth SJ, Navarrete C, Estcourt L, Marsh J. Platelet refractoriness\u2013practical approaches and ongoing dilemmas in patient management. Br J Haematol. 2015;171(3):297\u2013305.","journal-title":"Br J Haematol"},{"issue":"9","key":"16062_CR7","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1111\/j.1537-2995.2008.01799.x","volume":"48","author":"JL Kerkhoffs","year":"2008","unstructured":"Kerkhoffs JL, Eikenboom JC, van de Watering LM, van Wordragen-Vlaswinkel RJ, Wijermans PW, Brand A. The clinical impact of platelet refractoriness: correlation with bleeding and survival. Transfusion. 2008;48(9):1959\u201365.","journal-title":"Transfusion"},{"issue":"1","key":"16062_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/bjh.16291","volume":"189","author":"PF Ypma","year":"2020","unstructured":"Ypma PF, van Geloven N, Kerkhoffs JLH, Te Boekhorst P, Zwaginga JJ, Beckers EAM, et al. The association between haemorrhage and markers of endothelial insufficiency and inflammation in patients with hypoproliferative thrombocytopenia: a cohort study. Br J Haematol. 2020;189(1):171\u201381.","journal-title":"Br J Haematol"},{"issue":"1","key":"16062_CR9","doi-asserted-by":"publisher","first-page":"2229905","DOI":"10.1080\/09537104.2023.2229905","volume":"34","author":"X Song","year":"2023","unstructured":"Song X, Qi J, Li X, Zhou M, He J, Chu T, et al. Exploration of risk factors of platelet transfusion refractoriness and its impact on the prognosis of hematopoietic stem cell transplantation: a retrospective study of patients with hematological diseases. Platelets. 2023;34(1):2229905.","journal-title":"Platelets"},{"issue":"2","key":"16062_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/CIRCRESAHA.117.310795","volume":"122","author":"M Koupenova","year":"2018","unstructured":"Koupenova M, Clancy L, Corkrey HA, Freedman JE. Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis. Circ Res. 2018;122(2):337\u201351.","journal-title":"Circ Res"},{"issue":"11","key":"16062_CR11","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.1182\/blood-2008-01-078204","volume":"111","author":"DD Wagner","year":"2008","unstructured":"Wagner DD, Frenette PS. The vessel wall and its interactions. Blood. 2008;111(11):5271\u201381.","journal-title":"Blood"},{"issue":"7","key":"16062_CR12","doi-asserted-by":"publisher","first-page":"e1002098","DOI":"10.1371\/journal.ppat.1002098","volume":"7","author":"A Crawford","year":"2011","unstructured":"Crawford A, Angelosanto JM, Nadwodny KL, Blackburn SD, Wherry EJ. A role for the chemokine RANTES in regulating CD8 T cell responses during chronic viral infection. PLoS Pathog. 2011;7(7):e1002098.","journal-title":"PLoS Pathog"},{"issue":"9","key":"16062_CR13","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1111\/j.1537-2995.2007.01345.x","volume":"47","author":"S Nevo","year":"2007","unstructured":"Nevo S, Fuller AK, Zahurak ML, Hartley E, Borinsky ME, Vogelsang GB. Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 10(9) or 20 x 10(9) per L. Transfusion. 2007;47(9):1700\u20139.","journal-title":"Transfusion"},{"issue":"1","key":"16062_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1365-2141.2008.06999.x","volume":"141","author":"F Cognasse","year":"2008","unstructured":"Cognasse F, Hamzeh-Cognasse H, Lafarge S, Delezay O, Pozzetto B, McNicol A, et al. Toll-like receptor 4 ligand can differentially modulate the release of cytokines by human platelets. Br J Haematol. 2008;141(1):84\u201391.","journal-title":"Br J Haematol"},{"issue":"10","key":"16062_CR15","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","volume":"105","author":"SJ Slichter","year":"2005","unstructured":"Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, Kao KJ, et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood. 2005;105(10):4106\u201314.","journal-title":"Blood"},{"issue":"14","key":"16062_CR16","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/cncr.30057","volume":"122","author":"Q Qi","year":"2016","unstructured":"Qi Q, Zhuang L, Shen Y, Geng Y, Yu S, Chen H, et al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer. 2016;122(14):2158\u201367.","journal-title":"Cancer"},{"issue":"5","key":"16062_CR17","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/jnci\/djac022","volume":"114","author":"EK Belcher","year":"2022","unstructured":"Belcher EK, Culakova E, Gilmore NJ, Hardy SJ, Kleckner AS, Kleckner IR, et al. Inflammation, Attention, and Processing Speed in Patients With Breast Cancer Before and After Chemotherapy. J Natl Cancer Inst. 2022;114(5):712\u201321.","journal-title":"J Natl Cancer Inst"},{"issue":"17","key":"16062_CR18","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJM198710223171717","volume":"317","author":"RD Mosteller","year":"1987","unstructured":"Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317(17):1098.","journal-title":"N Engl J Med"},{"issue":"1","key":"16062_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47(1):207\u201314.","journal-title":"Cancer"},{"issue":"3","key":"16062_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1200\/JCO.2017.76.1734","volume":"36","author":"CA Schiffer","year":"2018","unstructured":"Schiffer CA, Bohlke K, Delaney M, Hume H, Magdalinski AJ, McCullough JJ, et al. Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2018;36(3):283\u201399.","journal-title":"J Clin Oncol"},{"issue":"12","key":"16062_CR21","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1093\/humrep\/deh533","volume":"19","author":"CA Williams","year":"2004","unstructured":"Williams CA, Wallace MR, Drury KC, Kipersztok S, Edwards RK, Williams RS, et al. Blood lymphocyte chimerism associated with IVF and monochorionic dizygous twinning: case report. Hum Reprod. 2004;19(12):2816\u201321.","journal-title":"Hum Reprod"},{"issue":"25","key":"16062_CR22","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1161\/01.CIR.0000077912.12202.FC","volume":"107","author":"DS Conway","year":"2003","unstructured":"Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation. Circulation. 2003;107(25):3141\u20135.","journal-title":"Circulation"},{"issue":"10","key":"16062_CR23","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1136\/gut.52.10.1435","volume":"52","author":"S Danese","year":"2003","unstructured":"Danese S, Katz JA, Saibeni S, Papa A, Gasbarrini A, Vecchi M, et al. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut. 2003;52(10):1435\u201341.","journal-title":"Gut"},{"issue":"10","key":"16062_CR24","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nri2171","volume":"7","author":"JS Pober","year":"2007","unstructured":"Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 2007;7(10):803\u201315.","journal-title":"Nat Rev Immunol"},{"issue":"15","key":"16062_CR25","doi-asserted-by":"publisher","first-page":"e2004433","DOI":"10.1002\/advs.202004433","volume":"8","author":"C Liu","year":"2021","unstructured":"Liu C, Chu D, Kalantar-Zadeh K, George J, Young HA, Liu G. Cytokines: From Clinical Significance to Quantification. Adv Sci (Weinh). 2021;8(15):e2004433.","journal-title":"Adv Sci (Weinh)"},{"key":"16062_CR26","doi-asserted-by":"publisher","first-page":"702152","DOI":"10.3389\/fphar.2021.702152","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liang B, Liu Y, Wei G, Wu W, Yang L, et al. Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed\/Refractory Acute Lymphoblastic Leukemia. Front Pharmacol. 2021;12:702152.","journal-title":"Front Pharmacol"},{"key":"16062_CR27","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJM196205032661802","volume":"266","author":"LA Gaydos","year":"1962","unstructured":"Gaydos LA, Freireich EJ, Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med. 1962;266:905\u20139.","journal-title":"N Engl J Med"},{"issue":"6","key":"16062_CR28","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3324\/haematol.2014.118075","volume":"100","author":"SJ Stanworth","year":"2015","unstructured":"Stanworth SJ, Hudson CL, Estcourt LJ, Johnson RJ, Wood EM, investigators Ts. Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis. Haematologica. 2015;100(6):740\u20137.","journal-title":"Haematologica"},{"issue":"11","key":"16062_CR29","first-page":"1530","volume":"91","author":"K Webert","year":"2006","unstructured":"Webert K, Cook RJ, Sigouin CS, Rebulla P, Heddle NM. The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia. Haematologica. 2006;91(11):1530\u20137.","journal-title":"Haematologica"},{"key":"16062_CR30","doi-asserted-by":"publisher","first-page":"204062072412376","DOI":"10.1177\/20406207241237606","volume":"15","author":"Y Qin","year":"2024","unstructured":"Qin Y, Wang Y, Zhang Y, Jiao Y, Ye J. Avatrombopag for the salvage treatment of platelet transfusion refractoriness. Ther Adv Hematol. 2024;15:20406207241237606.","journal-title":"Ther Adv Hematol"},{"key":"16062_CR31","doi-asserted-by":"publisher","first-page":"102863","DOI":"10.1016\/j.jaut.2022.102863","volume":"132","author":"Y Liu","year":"2022","unstructured":"Liu Y, Yu X, Zhang W, Zhang X, Wang M, Ji F. Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus. J Autoimmun. 2022;132:102863.","journal-title":"J Autoimmun"},{"issue":"4","key":"16062_CR32","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1161\/ATVBAHA.116.308126","volume":"37","author":"S Nhek","year":"2017","unstructured":"Nhek S, Clancy R, Lee KA, Allen NM, Barrett TJ, Marcantoni E, et al. Activated Platelets Induce Endothelial Cell Activation via an Interleukin-1beta Pathway in Systemic Lupus Erythematosus. Arterioscler Thromb Vasc Biol. 2017;37(4):707\u201316.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"47","key":"16062_CR33","doi-asserted-by":"publisher","first-page":"47ra63","DOI":"10.1126\/scitranslmed.3001001","volume":"2","author":"P Duffau","year":"2010","unstructured":"Duffau P, Seneschal J, Nicco C, Richez C, Lazaro E, Douchet I, et al. Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus. Sci Transl Med. 2010;2(47):47ra63.","journal-title":"Sci Transl Med"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16062-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16062-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16062-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:55:30Z","timestamp":1780959330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16062-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16062"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16062-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was conducted in accordance with the Declaration of Helsinki and was approved by the Medical Ethics Committee of the Children\u2019s Hospital, Zhejiang University School of Medicine (Hangzhou, China) (Approval No: 2022-IRB-240). The requirement for informed consent to participate was waived by the same committee due to the retrospective analysis of anonymized clinical data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"730"}}